A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein e-deficient mice
Event:
ESC Congress 2023
Topic:
Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session:
Atherosclerosis
